Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Financial writer recommends buying LifeVantage stock after exceeding Q2/FY2025 expectations with new MindBody GLP-1 System launch.

Many medications that are commonly referred to as "weight loss drugs" are not actually FDA-approved for this purpose. One of ...

Recent market research reveals that glucagon-like peptide-1 (GLP-1) injections are set to dominate the obesity treatment ...

In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two main factors: human resources and finance. On one side, there's the potential ...

Jonathan Van Ness has credited weight-loss medication for helping bring his binge eating disorder under control. The 'Queer ...

A mother’s health is the foundation of a thriving family. When a mother prioritizes her physical, emotional, and mental ...

Growing concerns suggest Gen Z might be aging faster biologically due to elevated cortisol levels. Factors such as academic ...

Viking Therapeutics has begun a Phase II clinical trial of VK2735 aimed at treating metabolic disorders, such as obesity.

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myelomaSarclisa SC formulation added to ...